Author
Listed:
- Patrick D. Rädler
(Barbara Ann Karmanos Cancer Institute
University of Nebraska Medical Center)
- Barbara L. Wehde
(University of Nebraska Medical Center)
- Aleata A. Triplett
(University of Nebraska Medical Center)
- Hridaya Shrestha
(Barbara Ann Karmanos Cancer Institute)
- Jonathan H. Shepherd
(University of North Carolina at Chapel Hill)
- Adam D. Pfefferle
(University of North Carolina at Chapel Hill)
- Hallgeir Rui
(Medical College of Wisconsin)
- Robert D. Cardiff
(University of California)
- Charles M. Perou
(University of North Carolina at Chapel Hill)
- Kay-Uwe Wagner
(Barbara Ann Karmanos Cancer Institute)
Abstract
Claudin-low breast cancer represents an aggressive molecular subtype that is comprised of mostly triple-negative mammary tumor cells that possess stem cell-like and mesenchymal features. Little is known about the cellular origin and oncogenic drivers that promote claudin-low breast cancer. In this study, we show that persistent oncogenic RAS signaling causes highly metastatic triple-negative mammary tumors in mice. More importantly, the activation of endogenous mutant KRAS and expression of exogenous KRAS specifically in luminal epithelial cells in a continuous and differentiation stage-independent manner induces preneoplastic lesions that evolve into basal-like and claudin-low mammary cancers. Further investigations demonstrate that the continuous signaling of oncogenic RAS, as well as regulators of EMT, play a crucial role in the cellular plasticity and maintenance of the mesenchymal and stem cell characteristics of claudin-low mammary cancer cells.
Suggested Citation
Patrick D. Rädler & Barbara L. Wehde & Aleata A. Triplett & Hridaya Shrestha & Jonathan H. Shepherd & Adam D. Pfefferle & Hallgeir Rui & Robert D. Cardiff & Charles M. Perou & Kay-Uwe Wagner, 2021.
"Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells,"
Nature Communications, Nature, vol. 12(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23957-5
DOI: 10.1038/s41467-021-23957-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23957-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.